BBIO
NASDAQ · Biotechnology
Bridgebio Pharma Inc
$84.48
+1.68 (+2.03%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+16.86%
1Y
+81.37%
YTD
+7.98%
Open$83.72
Previous Close$82.80
Day High$85.03
Day Low$82.24
52W High$93.42
52W Low$42.09
Volume—
Avg Volume2.02M
Market Cap16.61B
P/E Ratio—
EPS$-3.75
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$75.38
Above
SMA 200
$56.39
Above
RSI (14)
38.4
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
30 analysts
Price Target
+125.0% upside
Current
$84.48
$84.48
Target
$190.06
$190.06
$141.92
$190.06 avg
$243.96
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 515.29M | 276.59M | 2.34B |
| Net Income | -744,019,304 | -359,429,615 | -436,239,166 |
| Profit Margin | -144.4% | -137.2% | -18.6% |
| EBITDA | -553,326,272 | -282,157,787 | -548,703,476 |
| Free Cash Flow | — | — | -421,297,535 |
| Rev Growth | +86.3% | +86.3% | -0.2% |
| Debt/Equity | 8.27 | 8.27 | 0.84 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |